UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Patients with advanced cancer and their spouses parenting minor children: The role of the relationship context in parenting concerns

Psycho-oncology (Chichester, England), 2024-03, Vol.33 (3), p.e6310-n/a

2024

Volltextzugriff (PDF)

Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II study

Investigational new drugs, 2019-04, Vol.37 (2), p.345-351

2019

Volltextzugriff (PDF)

Trends in Sentinel Lymph Node Biopsies in Patients With Inflammatory Breast Cancer in the US

JAMA network open, 2022-02, Vol.5 (2), p.e2148021-e2148021

2022

Volltextzugriff (PDF)

Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and ASCO Guideline

Journal of clinical oncology, 2021-09, Vol.39 (27), p.3056-3082

2021

Volltextzugriff (PDF)

2022-RA-848-ESGO Obstetric and neonatal outcomes after breast cancer: a population-based study

International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A176-A176

2022

Volltextzugriff (PDF)

Impact of delayed neoadjuvant systemic chemotherapy on survival outcomes in breast cancer patients

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.1038-1038

2016

Volltextzugriff (PDF)

Tamoxifen therapy for patients with breast cancer

The Lancet (British edition), 2013-06, Vol.381 (9883), p.2077-2078

2013

Volltextzugriff (PDF)

Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinoma

SpringerPlus, 2013-08, Vol.2 (1), p.409-409, Article 409

2013

Volltextzugriff (PDF)

Advice from one patient to another: A qualitative analysis of patients’ perspectives about chemotherapy initiation

Journal of clinical oncology, 2022-10, Vol.40 (28_suppl), p.255-255

2022

Volltextzugriff (PDF)

Incidence and severity of neutropenia in patients treated with cyclin-dependent kinase 4/6 inhibitors (CDKi) for metastatic breast cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e13036-e13036

2022

Volltextzugriff (PDF)

A qualitative study informing about barriers and facilitators associated to chemotherapy initiation among breast cancer patients: Next steps for an intervention

Journal of clinical oncology, 2021-10, Vol.39 (28_suppl), p.247-247

2021

Volltextzugriff (PDF)

Impact of Medicaid expansion on two-year mortality among stage IV breast cancer (BC) patients according to race

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.6525-6525

2021

Volltextzugriff (PDF)

Impact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancers

Cancer, 2012-03, Vol.118 (6), p.1498-1506

2012

Volltextzugriff (PDF)

Exploratory biomarker analysis of acelERA breast cancer (BC): Phase II study of giredestrant vs. physician’s choice of endocrine therapy (PCET) for previously treated, estrogen receptor-positive, HER2-negative advanced BC (ER+, HER2– aBC)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.1069-1069

2023

Volltextzugriff (PDF)

acelERA Breast Cancer (BC): Phase II study evaluating efficacy and safety of giredestrant (GDC-9545) versus physician’s choice of endocrine monotherapy in patients (pts) with estrogen receptor-positive, HER2-negative (ER+/HER2-) locally advanced or metastatic breast cancer (LA/mBC)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.TPS1100-TPS1100

2021

Volltextzugriff (PDF)

Abstract PS1-17: Comparing survival differences between breast-conserving therapy and mastectomy in patients with early-stage breast cancer undergoing upfront surgery

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS1-17-PS1-17

2021

Volltextzugriff (PDF)

Racial/ethnic disparities in locoregional recurrence in hormone-receptor positive node-negative breast cancer patients enrolled in the TAILORx trial

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.515-515

2022

Volltextzugriff (PDF)

Overall survival (OS) with first-line palbociclib plus letrozole (PAL+LET) versus placebo plus letrozole (PBO+LET) in women with estrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer (ER+/HER2− ABC): Analyses from PALOMA-2

Journal of clinical oncology, 2022-06, Vol.40 (17_suppl), p.LBA1003-LBA1003

2022

Volltextzugriff (PDF)

Obstetric and Neonatal Outcomes 1 or More Years After a Diagnosis of Breast Cancer

Obstetrics and gynecology (New York. 1953), 2022-12, Vol.140 (6), p.939

2022

Volltextzugriff (PDF)

Pregnancy after breast cancer: A population-based study of survival and obstetric outcomes

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e18783-e18783

2021

Volltextzugriff (PDF)

Outcomes related to delayed initiation of anti-HER 2 therapy in pregnant HER2 positive breast cancer patients

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e12059-e12059

2017

Volltextzugriff (PDF)

Comparing Survival Differences Between Breast-Conserving Therapy and Mastectomy in Patients with Early-Stage Breast Cancer

International journal of radiation oncology, biology, physics, 2020-10, Vol.108 (2), p.E26-E26

2020

Volltextzugriff (PDF)

Antiemesis prophylaxis among breast cancer (BC) patients receiving highly emetogenic chemotherapy

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e12005-e12005

2015

Volltextzugriff (PDF)

Use and adherence to breast cancer risk-reduction agents: A population-based study

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.1558-1558

2016

Volltextzugriff (PDF)

Validation of the AJCC 8 th edition prognostic stage in breast cancer

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e23186-e23186

2017

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(56)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(9)
Oncology
(8)
Science & Technology
(8)
Breast Cancer
(7)
Female
(7)
Life Sciences & Biomedicine
(7)
Adult
(4)
Aged
(3)
Breast Neoplasms - Drug Therapy
(3)
Middle Aged
(3)
Retrospective Studies
(3)
Antineoplastic Agents, Hormonal - Administration & Dosage
(2)
Cancer
(2)
Cesarean Section
(2)
Internal Medicine
(2)
Postmenopause
(2)
Prognosis
(2)
Tamoxifen - Administration & Dosage
(2)
Time Factors
(2)
Womens Health
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Patients with advanced cancer and their spouses parenting minor children: The role of the relationship context in parenting concerns

Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II study

Trends in Sentinel Lymph Node Biopsies in Patients With Inflammatory Breast Cancer in the US

Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and ASCO Guideline

2022-RA-848-ESGO Obstetric and neonatal outcomes after breast cancer: a population-based study

Impact of delayed neoadjuvant systemic chemotherapy on survival outcomes in breast cancer patients

Tamoxifen therapy for patients with breast cancer

Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinoma

Advice from one patient to another: A qualitative analysis of patients’ perspectives about chemotherapy initiation

Incidence and severity of neutropenia in patients treated with cyclin-dependent kinase 4/6 inhibitors (CDKi) for metastatic breast cancer

A qualitative study informing about barriers and facilitators associated to chemotherapy initiation among breast cancer patients: Next steps for an intervention

Impact of Medicaid expansion on two-year mortality among stage IV breast cancer (BC) patients according to race

Impact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancers

Exploratory biomarker analysis of acelERA breast cancer (BC): Phase II study of giredestrant vs. physician’s choice of endocrine therapy (PCET) for previously treated, estrogen receptor-positive, HER2-negative advanced BC (ER+, HER2– aBC)

acelERA Breast Cancer (BC): Phase II study evaluating efficacy and safety of giredestrant (GDC-9545) versus physician’s choice of endocrine monotherapy in patients (pts) with estrogen receptor-positive, HER2-negative (ER+/HER2-) locally advanced or metastatic breast cancer (LA/mBC)

Abstract PS1-17: Comparing survival differences between breast-conserving therapy and mastectomy in patients with early-stage breast cancer undergoing upfront surgery

Racial/ethnic disparities in locoregional recurrence in hormone-receptor positive node-negative breast cancer patients enrolled in the TAILORx trial

Overall survival (OS) with first-line palbociclib plus letrozole (PAL+LET) versus placebo plus letrozole (PBO+LET) in women with estrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer (ER+/HER2− ABC): Analyses from PALOMA-2

Obstetric and Neonatal Outcomes 1 or More Years After a Diagnosis of Breast Cancer

Pregnancy after breast cancer: A population-based study of survival and obstetric outcomes

Outcomes related to delayed initiation of anti-HER 2 therapy in pregnant HER2 positive breast cancer patients

Comparing Survival Differences Between Breast-Conserving Therapy and Mastectomy in Patients with Early-Stage Breast Cancer

Antiemesis prophylaxis among breast cancer (BC) patients receiving highly emetogenic chemotherapy

Use and adherence to breast cancer risk-reduction agents: A population-based study

Validation of the AJCC 8 th edition prognostic stage in breast cancer

Suchergebnisse filtern